$5.910
-0.030 (-0.51%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
EBS Prediction & Forecast by Similar Chart Analysis
Alphio's EBS stock price prediction model matches the current Emergent BioSolutions Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.95 (+0.61%). The 1-week path is $5.87 (-0.74%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Emergent BioSolutions Inc Stock?
Emergent BioSolutions Inc (EBS) is not a good buy right now due to a significant net loss of $180.2 million reported in Q2 2026, alongside a current price of $5.91 that is well below its 200-day moving average of $9.14. Additionally, the RSI is at 72.702, indicating the stock is overbought, and insider selling has increased by 140.86%, suggesting a lack of confidence from those within the company. The main risk is the company's ongoing transition phase and competition in the naloxone market, which has led to lowered earnings expectations and price target cuts from analysts.
EBS stock price ended at $5.91 on Friday, after losing -0.51%
Emergent BioSolutions Inc (EBS) last closed at $5.91, losing -0.51%. These facts feed the 1-day and 1-week EBS price prediction above.
Analyst Consensus
Emergent BioSolutions Inc (EBS): 5 buy, 1 hold, 0 sell. Outlook: Strong Buy.
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
Forecast Drivers
Emergent BioSolutions Inc (EBS) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches EBS, ranked by similarity.
Seasonality analysis for EBS
Historically the probability of a positive August return for EBS is 34.92%. December offers the highest probability of a positive month at 100.00%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for EBS
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $3.45 | $5.34 | $7.51 | -9.56% |
| Sep 2026 | $5.05 | $6.25 | $6.27 | +5.83% |
| Oct 2026 | $6.63 | $7.63 | $9.10 | +29.14% |
| Nov 2026 | $4.09 | $6.02 | $8.10 | +1.82% |
| Dec 2026 | $4.14 | $6.42 | $7.49 | +8.67% |
In 2026, Emergent BioSolutions Inc (EBS) is projected to range from $3.45 to $9.10.
Emergent BioSolutions Inc 2026 monthly forecast
In Aug 2026, Emergent BioSolutions Inc is projected to average $5.34, with a low of $3.45 and high of $7.51.
In Sep 2026, Emergent BioSolutions Inc is projected to average $6.25, with a low of $5.05 and high of $6.27.
In Oct 2026, Emergent BioSolutions Inc is projected to average $7.63, with a low of $6.63 and high of $9.10.
In Nov 2026, Emergent BioSolutions Inc is projected to average $6.02, with a low of $4.09 and high of $8.10.
In Dec 2026, Emergent BioSolutions Inc is projected to average $6.42, with a low of $4.14 and high of $7.49.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.